Compare TRIB & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TRIB | COSM |
|---|---|---|
| Founded | 1992 | 2009 |
| Country | Ireland | United States |
| Employees | N/A | 163 |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Other Pharmaceuticals |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.0M | 15.8M |
| IPO Year | 1996 | 2009 |
| Metric | TRIB | COSM |
|---|---|---|
| Price | $0.56 | $0.28 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 76.3K | ★ 758.2K |
| Earning Date | 05-22-2026 | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 46.15 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $65,271,815.00 |
| Revenue This Year | $13.51 | $54.08 |
| Revenue Next Year | $13.14 | $32.66 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.93 |
| 52 Week Low | $0.50 | $0.28 |
| 52 Week High | $3.44 | $1.32 |
| Indicator | TRIB | COSM |
|---|---|---|
| Relative Strength Index (RSI) | 37.59 | 31.41 |
| Support Level | $0.50 | N/A |
| Resistance Level | $0.76 | $0.41 |
| Average True Range (ATR) | 0.04 | 0.02 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 13.90 | 0.84 |
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.